Adoptive immunotherapy for posttransplantation viral infections
Open Access
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (3) , 143-155
- https://doi.org/10.1016/j.bbmt.2003.09.017
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cellsNature Medicine, 2003
- Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBNature Biotechnology, 2002
- Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive IndividualsThe Journal of Immunology, 2002
- Factors affecting thymic function after allogeneic hematopoietic stem cell transplantationBlood, 2001
- Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cellsNature Biotechnology, 2000
- Semiquantitative Epstein-Barr Virus (EBV) Polymerase Chain Reaction for the Determination of Patients at Risk for EBV-Induced Lymphoproliferative Disease After Stem Cell TransplantationBlood, 1998
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative diseaseBritish Journal of Haematology, 1995
- Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter]Blood, 1994
- Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1994